Clinical Trial Update: Evaluation of the Role of Magnesium in Prevention of AF Post Cardiac Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating magnesium sulfate for prevention of atrial fibrillation after cardiac surgery; the study is completed and results were posted in 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Ain Shams University | Conditions: Atrial Fibrillation (AF), Magnesium Sulfate | Phase 3 | Status: COMPLETED | Results posted: 2025-08-17